Southeastern Section of the American Urological Association SES AUA 2026
SES AUA 2026 Prostate Cancer
- SES AUA 2026: The State of the Urology Workforce
- SES AUA 2026: Patient Perspectives on Pre-Treatment Counseling for Prostate Cancer: A Qualitative Analysis on Patient Communication
- SES AUA 2026: Darolutamide Plus Androgen-Deprivation Therapy in Patients with Metastatic Hormone-Sensitive Prostate Cancer: Efficacy and Safety by Disease Volume in the Phase 3 ARANOTE Study
- SES AUA 2026: PSA and Alkaline Phosphatase Decline in the EORTC-1333 PEACE-3 Study Evaluating the Addition of Radium-223 in mCRPC Starting Enzalutamide
- SES AUA 2026: Pathways for Prostate Cancer Evaluation: Guidelines, Tools, and Best Practices to Optimize PSA Based Screening
SES AUA 2026 Bladder Cancer
- SES AUA 2026: Differences in Restaging TURBT Pathology Outcomes Based on Index TURBT Performed by an SUO Fellowship Trained or Non-SUO Trained Urologist  
- SES AUA 2026: Novel FDA Drug Repurposing Strategies for High-Mortality Urologic Cancers: A TCGA-Based Molecular Analysis
- SES AUA 2026: Bladder Cancer Burden from Smoking: Mortality and Disability-Adjusted Life Years in Relation to United States Tobacco Taxation
- SES AUA 2026: Application of Machine Learning Models for Predicting Postoperative Ileus after Radical Cystectomy
- SES AUA 2026: Patient Time Toxicity from Management Options for NMIBC